Maanya Biotech Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -423.58%
- Ebitda -114.49%
- Net Worth -0.71%
- Total Assets -0.02%
About Maanya Biotech
Maanya Biotech Limited (MBL) is a Public Limited Indian Non-Government Company incorporated in India on 17 July 1995 and has a history of 29 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Manivardhan Yala, Agraharam Kumar, and Saamya Yala serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239TG1995PLC021052
- Company No.
021052
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1995
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Maanya Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manivardhan Yala  | Additional Director | 12-Jan-2021 | Current |
| Agraharam Kumar | Director | 09-Jul-2019 | Current |
| Saamya Yala | Additional Director | 19-Jan-2017 | Current |
Financial Performance of Maanya Biotech.
Maanya Biotech Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 423.58% decrease in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maanya Biotech?
In 2018, Maanya Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saamya Biotech (India) LimitedManivardhan Yala is a mutual person
Sree Ekadanta Engineering Consultants Private LimitedManivardhan Yala and Saamya Yala are mutual person
- Maanya Genics Private Limited
Saamya Yala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maanya Biotech?
Unlock and access historical data on people associated with Maanya Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maanya Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maanya Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
